Annual Accounts Payable
$4.26 M
+$982.00 K+29.97%
December 1, 2024
Summary
- As of March 10, 2025, TRDA annual accounts payable is $4.26 million, with the most recent change of +$982.00 thousand (+29.97%) on December 1, 2024.
- During the last 3 years, TRDA annual accounts payable has risen by +$3.55 million (+503.26%).
- TRDA annual accounts payable is now -28.90% below its all-time high of $5.99 million, reached on December 31, 2022.
Performance
TRDA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$4.26 M
+$2.97 M+229.64%
December 1, 2024
Summary
- As of March 10, 2025, TRDA quarterly accounts payable is $4.26 million, with the most recent change of +$2.97 million (+229.64%) on December 1, 2024.
- Over the past year, TRDA quarterly accounts payable has stayed the same.
- TRDA quarterly accounts payable is now -34.21% below its all-time high of $6.47 million, reached on March 31, 2023.
Performance
TRDA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
TRDA Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.0% | 0.0% |
| 3 y3 years | +503.3% | -28.9% |
| 5 y5 years | +499.9% | -28.9% |
TRDA Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -28.9% | +503.3% | -34.2% | +503.3% |
| 5 y | 5-year | -28.9% | +503.3% | -34.2% | +503.3% |
| alltime | all time | -28.9% | +503.3% | -34.2% | +503.3% |
Entrada Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $4.26 M(+30.0%) | $4.26 M(+229.6%) |
| Sep 2024 | - | $1.29 M(-21.0%) |
| Jun 2024 | - | $1.64 M(-35.3%) |
| Mar 2024 | - | $2.53 M(-22.9%) |
| Dec 2023 | $3.28 M(-45.3%) | $3.28 M(+335.8%) |
| Sep 2023 | - | $752.00 K(-69.0%) |
| Jun 2023 | - | $2.42 M(-62.6%) |
| Mar 2023 | - | $6.47 M(+8.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $5.99 M(+748.4%) | $5.99 M(+346.7%) |
| Sep 2022 | - | $1.34 M(-71.0%) |
| Jun 2022 | - | $4.62 M(+57.7%) |
| Mar 2022 | - | $2.93 M(+315.2%) |
| Dec 2021 | $706.00 K(-55.9%) | $706.00 K(-69.0%) |
| Sep 2021 | - | $2.28 M(+21.1%) |
| Jun 2021 | - | $1.88 M(+17.4%) |
| Dec 2020 | $1.60 M(+125.6%) | $1.60 M |
| Dec 2019 | $710.00 K | - |
FAQ
- What is Entrada Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Entrada Therapeutics?
- What is Entrada Therapeutics annual accounts payable year-on-year change?
- What is Entrada Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Entrada Therapeutics?
- What is Entrada Therapeutics quarterly accounts payable year-on-year change?
What is Entrada Therapeutics annual accounts payable?
The current annual accounts payable of TRDA is $4.26 M
What is the all time high annual accounts payable for Entrada Therapeutics?
Entrada Therapeutics all-time high annual accounts payable is $5.99 M
What is Entrada Therapeutics annual accounts payable year-on-year change?
Over the past year, TRDA annual accounts payable has changed by +$982.00 K (+29.97%)
What is Entrada Therapeutics quarterly accounts payable?
The current quarterly accounts payable of TRDA is $4.26 M
What is the all time high quarterly accounts payable for Entrada Therapeutics?
Entrada Therapeutics all-time high quarterly accounts payable is $6.47 M
What is Entrada Therapeutics quarterly accounts payable year-on-year change?
Over the past year, TRDA quarterly accounts payable has changed by $0.00 (0.00%)